CAHCARDINAL HEALTH INC
Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Revenue
- $254.2B
- 14% YoY
- Operating margin
- 1.0%
- 0.6% YoY
- EBITDA
- $3.6B
- 16% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 1.2×
- $4.2B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear302% of net incomeCash flow under 80% of net income
- Dilutive SBCClear0% of revenueOver 10% of revenue
- Payouts exceed cash flowClear36% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear20% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $181.3B | $205.0B | $226.8B | $222.6B | $254.2B | 14% |
| Operating income | −$607M | $752M | $1.2B | $2.3B | $2.6B | 15% |
| Net income | −$938M | $330M | $852M | $1.6B | $1.7B | 9.8% |
| Operating cash flow | $3.2B | $2.8B | $3.8B | $2.4B | $5.2B | 116% |
| Capex | $387M | $481M | $511M | $547M | $649M | 19% |
| Stock-based comp | $81M | $96M | $121M | $244M | $367M | 50% |
| Buybacks | $1.0B | $2.0B | $750M | $765M | $1.4B | 78% |
| Dividends | $559M | $525M | $499M | $494M | $491M | 0.6% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2026 | — | — | 463 | 137 |
| FY2025 | — | — | 324 | 114 |
| FY2024 | — | — | 186 | 121 |
| FY2023 | — | — | 176 | 109 |
| FY2022 | — | — | 95 | 103 |